drug discovery tool

A unique collection of 2975 approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1960 FDA approved drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1800 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1385 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 4655 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 1639 compounds from food as medicine for high throughput and high content screening;

A collection of 1321 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study;

A unique collection of 3011 compounds (TCM monomers) sourcing from traditional Chinese Medicines, is a powerful tool for drug discovery and research in mechanism;

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 5120 approved and clinical drugs for high throughput screening (HTS) and high content screening (HCS);

The unparalleled chemical diversity of natural products makes them an ideal choice for screening active small molecules. Natural products is always a significant source in drug discovery. According to authoritative statistics, 79 out of 99 small molecule anticancer drugs have been successfully developed based on natural products since 1981. Natural products have demonstrated successful modulation of isolated but crucial targets, especially in antimicrobial targets and protein interactions. Many researchers consider natural products and their derivatives as unique tools for studying and manipulating protein function. The Drug-like Natural Compound Library comprises 522 novel molecules, serving as a complement to the L6000 Natural Product Library. This library enhances the probability of successful drug screening, making it an excellent tool for lead compound discovery.

A unique collection of 523 compounds acting on immune-oncology therapeutic targets can be used for high throughput and high content screening;

A unique collection of 2440 compounds with anti-breast cancer therapeutic activity or targeting breast cancer's major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study;

A unique collection of 941 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;

A unique collection of 1227 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 246 fragment-like small molecules for FBDD;

A unique collection of 23618 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening;

A unique collection of 2240 reprogramming signaling pathway-related bioactive small molecule compounds for high-throughput, high-content screening.

A unique collection of 779 ferroptosis signaling pathway related compounds, a powerful tool for new target identification, drug discovery, and mechanism study;

1119 drug fragments,a must-have tool for FBDD;